Auna Zukünftiges Wachstum
Future Kriterienprüfungen 3/6
Auna wird ein jährliches Gewinn- und Umsatzwachstum von 44% bzw. 6.1% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 35.8% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 14.4% betragen.
Wichtige Informationen
44.0%
Wachstumsrate der Gewinne
35.79%
EPS-Wachstumsrate
| Healthcare Gewinnwachstum | 18.4% |
| Wachstumsrate der Einnahmen | 6.1% |
| Zukünftige Eigenkapitalrendite | 14.42% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 20 May 2026 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Narrativ-Update • May 04
AUNA: Execution On 2026 Guidance Will Drive Reassessment Of Bearish Reset
Analysts have reduced their price target on Auna from $19.00 to $9.00, citing updated assumptions for discount rate, revenue growth, profit margins, and a lower future P/E following recent bearish Street research. Analyst Commentary Even with the lower headline target, some bullish analysts still see room for upside if Auna can deliver on key execution milestones and support the revised valuation assumptions.
Narrativ-Update • Apr 19
AUNA: Mexico Execution And 2026 Guidance Will Support Bullish Re‑Rating
Analysts have maintained their price target on Auna at $7.20, citing a mix of more cautious and more optimistic research views that reflect slightly updated assumptions for discount rates, growth and P/E multiples. Analyst Commentary Bullish Takeaways Bullish analysts point to the current $7.20 target as reasonable relative to their updated P/E assumptions, suggesting the valuation still lines up with their expectations for the business model and capital allocation.Narrativ-Update • Apr 05
AUNA: Mexico Execution And 2026 Guidance Will Support Long-Term Upside
Analysts have trimmed their price target for Auna from about $10.42 to $7.20, reflecting updated views on discount rates, revenue growth, profit margins and future P/E, following a mix of recent bullish and bearish research updates. Analyst Commentary Recent research on Auna shows a mix of optimism and caution, which helps explain the reduced price target and the current debate around the shares.
Narrativ-Update • Mar 22
AUNA: Mixed Research Views And 2026 Guidance Will Shape Execution Outlook
Auna's analyst price target has been updated to $6.00, with analysts citing mixed recent research that includes a more cautious stance from BTG Pactual, along with more constructive views from HSBC and Jefferies on the company outlook. Analyst Commentary Recent Street research on Auna points to a split view, with some analysts turning more constructive while others are sounding more cautious and adjusting ratings and price targets accordingly.Narrativ-Update • Mar 08
AUNA: Execution On Mixed Research Views Will Shape Future Upside Potential
Analysts have trimmed their Auna price target to $6.00, reflecting slightly adjusted assumptions around the discount rate, revenue growth, profit margins and future P/E after a mix of more cautious and more constructive recent research views. Analyst Commentary Recent research views on Auna have moved in different directions, with some firms turning more constructive and at least one becoming more cautious.Narrativ-Update • Feb 22
AUNA: Execution On Mixed Mexico Expansion Views Will Drive Future Upside
Analysts have nudged their price target on Auna up from $6.00 to $6.50, reflecting mixed but generally constructive research, with one firm turning more cautious even as others highlight potential for slightly better growth, margins, and a lower assumed future P/E. Analyst Commentary Recent research has not been uniformly positive, and some bearish analysts are clearly leaning more cautious on Auna, even as others highlight potential upside.Narrativ-Update • Feb 07
AUNA: Mexico Expansion And Leverage Execution Will Drive Upside Potential
Analysts have reduced their price target on Auna to $6.00 from $13.50, reflecting a more cautious stance as they weigh concerns about a slower ramp up in Mexico, elevated leverage, and mixed recent rating changes from BTG Pactual, HSBC, and Jefferies. Analyst Commentary Recent research shows a split in views on Auna, with some firms taking a more constructive stance while others highlight execution and balance sheet risks.Narrativ-Update • Jan 24
AUNA: Mexico Execution And Leverage Path Will Shape Balanced Upside Potential
Analysts have lifted their Auna price target to $6.00 from $6.00, keeping the fair value level steady while adjusting their view to reflect updated assumptions on discount rates, revenue growth, profit margins and future P/E in light of mixed but generally constructive recent research. Analyst Commentary Recent research on Auna has been mixed, with some firms taking a more constructive stance while others highlight ongoing execution and balance sheet questions.Analyseartikel • Jan 23
Does Auna (NYSE:AUNA) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Narrativ-Update • Jan 10
AUNA: Mexico Expansion Will Reframe Perceived Execution And Leverage Risks
Analysts have trimmed their price target on Auna to US$6 from US$13.50, pointing to a slower ramp-up in Mexico, a less supportive consolidated growth profile, and expectations that leverage will remain elevated. Analyst Commentary Recent Street research on Auna has turned more cautious, with JPMorgan cutting its rating to Neutral and lowering its price target to US$6 from US$13.50.Narrativ-Update • Dec 22
AUNA: Mexico Execution And Deleveraging Will Drive Long-Term Upside Potential
Analysts have trimmed their price target on Auna by roughly $0.25 to reflect a slightly lower fair value estimate and a modestly higher discount rate, citing concerns over slower than expected growth and sustained leverage highlighted in recent research. Analyst Commentary Analyst reactions to the latest developments at Auna have focused on the trade off between long term growth optionality and near term execution risks, particularly around the company's regional expansion and balance sheet trajectory.Narrativ-Update • Dec 08
AUNA: Mexico Expansion And Deleveraging Will Unlock Future Upside Potential
Analysts have lowered their price target on Auna from $13.50 to $6.00, citing a slower than expected ramp-up in Mexico, a less compelling consolidated growth profile, and persistently elevated leverage. Analyst Commentary Analyst views on Auna have turned more cautious following the recent downgrade and target price cut to $6.00, but the stock’s reset valuation is also seen as creating a more balanced risk reward profile.Narrativ-Update • Nov 24
AUNA: Future Expansion Plans In Mexico Will Unlock Growth Potential
Narrative Update: Analyst Price Target Change for Auna The average analyst price target for Auna was reduced from $12.08 to $10.67. Analysts point to a slower than expected operational ramp-up and persistent elevated leverage as key factors for the adjustment.Analyseartikel • Nov 14
Auna (NYSE:AUNA) Is Looking To Continue Growing Its Returns On Capital
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'd want to...Seeking Alpha • Jun 23
Auna: Scalable, Profitable, Misunderstood
Summary AUNA's integrated LatAm healthcare platform is undervalued due to short-term execution, not structural flaws. The payor-provider model drives superior margins, cost efficiencies, and creates a powerful ecosystem with strong operating leverage, especially in underutilized Mexican assets. Management is actively addressing physician onboarding and payor mix, with insurance-led strategies poised to drive patient volume and profitability recovery. Despite risks, AUNA's discounted valuation, robust growth, and leading margins make it a compelling Buy at current levels. Read the full article on Seeking AlphaNeues Narrativ • May 29
High-Efficiency Healthcare Model And Demographic Trends Will Shape Future Landscape
Operational challenges in Mexico are being addressed, while strong performance in Peru showcases the potential of Auna's value-based, integrated care model.Analyseartikel • Jan 29
A Piece Of The Puzzle Missing From Auna S.A.'s (NYSE:AUNA) 26% Share Price Climb
The Auna S.A. ( NYSE:AUNA ) share price has done very well over the last month, posting an excellent gain of 26%. While...Analyseartikel • Jan 19
Here's Why Auna (NYSE:AUNA) Has A Meaningful Debt Burden
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Seeking Alpha • Jan 15
Auna: Cheap Entry Level In Latin American Healthcare Play
Summary Auna is a leading player in the Spanish-speaking Latin America medical industry, focusing particularly on high-complexity diseases, such as cancer. Most SSLA have a highly fragmented and underserved healthcare market, and populations are becoming elderly, demanding more and better services. AUNA stock has been impacted negatively following its IPO process, as local institutional players such as pension funds overbought the stock and had to sell due to regulatory limits. AUNA stock trades currently below 6X EV / EBITDA, while revenues and EBITDA are growing at double digits. Patient investors should benefit from valuation normalization metrics and continued growth. Though it still has high leverage (Net Debt / EBITDA =3.7), it has been able to decrease it (from 6.8X in 2021) and has stable and growing operating cash flows (annual run rate USD250MM last quarter). Interest rate reductions should benefit the company. Read the full article on Seeking AlphaGewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2028 | 5,279 | 364 | 565 | 858 | 4 |
| 12/31/2027 | 5,019 | 285 | 509 | 579 | 7 |
| 12/31/2026 | 4,750 | 235 | 403 | 308 | 5 |
| 3/31/2026 | 4,521 | 69 | 601 | 731 | N/A |
| 12/31/2025 | 4,385 | 98 | 518 | 663 | N/A |
| 9/30/2025 | 4,316 | 187 | 471 | 633 | N/A |
| 6/30/2025 | 4,325 | 237 | 481 | 648 | N/A |
| 3/31/2025 | 4,352 | 159 | 456 | 620 | N/A |
| 12/31/2024 | 4,386 | 110 | 527 | 668 | N/A |
| 9/30/2024 | 4,344 | -123 | 473 | 621 | N/A |
| 6/30/2024 | 4,233 | -261 | 418 | 585 | N/A |
| 3/31/2024 | 4,058 | -263 | 419 | 585 | N/A |
| 12/31/2023 | 3,876 | -254 | 417 | 582 | N/A |
| 9/30/2023 | 3,659 | -112 | 392 | 535 | N/A |
| 6/30/2023 | 3,241 | -76 | 310 | 433 | N/A |
| 3/31/2023 | 2,861 | -100 | 231 | 361 | N/A |
| 12/31/2022 | 2,452 | -86 | 11 | 163 | N/A |
| 9/30/2022 | 2,118 | -65 | -123 | 123 | N/A |
| 6/30/2022 | 2,009 | -64 | -108 | 125 | N/A |
| 3/31/2022 | 1,937 | -35 | -190 | 93 | N/A |
| 12/31/2021 | 1,924 | -26 | -106 | 183 | N/A |
| 9/30/2021 | 1,874 | 20 | 8 | 216 | N/A |
| 6/30/2021 | 1,779 | 42 | -26 | 189 | N/A |
| 3/31/2021 | 1,577 | 51 | 38 | 180 | N/A |
| 12/31/2020 | 1,444 | -7 | 27 | 156 | N/A |
| 9/30/2020 | 1,373 | 28 | -12 | 124 | N/A |
| 6/30/2020 | 1,335 | 14 | -11 | 119 | N/A |
| 3/31/2020 | 1,381 | 16 | 3 | 143 | N/A |
| 12/31/2019 | 1,383 | 73 | N/A | 152 | N/A |
| 12/31/2018 | 861 | 36 | N/A | 109 | N/A |
| 12/31/2017 | 723 | 22 | N/A | 96 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: AUNADas prognostizierte Gewinnwachstum (44% pro Jahr) liegt über der Sparquote (3.5%).
Ertrag vs. Markt: AUNADie Erträge des Unternehmens (44% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (16.8% pro Jahr).
Hohe Wachstumserträge: AUNAEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.
Einnahmen vs. Markt: AUNADie Einnahmen des Unternehmens (6.1% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (11.7% pro Jahr).
Hohe Wachstumseinnahmen: AUNADie Einnahmen des Unternehmens (6.1% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: AUNADie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (14.4%).
Wachstumsunternehmen entdecken
Unternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/05/24 09:25 |
| Aktienkurs zum Tagesende | 2026/05/22 00:00 |
| Gewinne | 2026/03/31 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
Auna S.A. wird von 8 Analysten beobachtet. 7 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Samuel Campos Alves | BTG Pactual |
| Leandro Bastos | Citigroup Inc |
| Leandro Bastos | Citigroup Inc |